Journal Article

Design of the Dutch multicentre study on opportunistic screening of geriatric patients for atrial fibrillation using a smartphone PPG app: the Dutch-GERAF study

Hemels, Martin E. W., Jansen, René W. M. M., Pisters, Ron, Spruit, Jocelyn R., Riezebos, Robert K., Zwart, Lennaert A. R., de Groot, Joris R.

2024

Overview

Background Screening of high-risk patients is advocated to achieve early detection and treatment of clinical atrial fibrillation (AF). The Dutch-GERAF study will address two major issues. Firstly, the effectiveness and feasibility of an opportunistic screening strategy for clinical AF will be assessed in frail older patients and, secondly, observational data will be gathered regarding the efficacy and safety of oral anticoagulation (OAC). Methods This is a multicentre study on opportunistic screening of geriatric patients for clinical AF using a smartphone photoplethysmography (PPG) application. Inclusion criteria are age ≥ 65 years and the ability to perform at least three PPG recordings within 6 months. Exclusion criteria are the presence of a cardiac implantable device, advanced dementia or a severe tremor. The PPG application records patients’ pulse at their fingertip and determines the likelihood of clinical AF. If clinical AF is suspected after a positive PPG recording, a confirmatory electrocardiogram is performed. Patients undergo a comprehensive geriatric assessment and a frailty index is calculated. Risk scores for major bleeding (MB) are applied. Standard laboratory testing and additional laboratory analyses are performed to determine the ABC-bleeding risk score. Follow-up data will be collected at 6 months, 12 months and 3 years on the incidence of AF, MB, hospitalisation, stroke, progression of cognitive disorders and mortality. Discussion The Dutch-GERAF study will focus on frail older patients, who are underrepresented in randomised clinical trials. It will provide insight into the effectiveness of screening for clinical AF and the efficacy and safety of OAC in this high-risk population. Trial registration NCT05337202.

• Publisher: Bohn Stafleu van Loghum,Springer Nature B.V
• Subject: Activities of daily living / Angina pectoris / Anticoagulants / Body mass index / Cardiac arrhythmia / Cardiology / Chronic obstructive pulmonary disease / Dementia / Electrocardiography / Frailty / Geriatrics / Heart / Ischemia / Medical Education / Medicine / Medicine & Public Health / Original Article – Study Design Article / Original – Study Design / Outpatient care facilities / Patients / Peptides / Polypharmacy / Smartphones / Stroke